drugset / Trial / NCT01376076

Effects of Cariprazine on Cardiac Repolarization in Patients With Schizophrenia

NCT01376076

Phase 1 Completed 129 enrolled Forest Laboratories
RandomizedParallel-groupTriple-blindTreatment

Summary

This study will evaluate the effects of sequential multiple dose regimens of cariprazine on cardiac repolarization in patients with schizophrenia.

Timeline

Start
2011-06
Primary completion
2012-02
Completion
2012-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Cariprazine Small molecule 18 mg Oral
Comparator Moxifloxacin Small molecule 400 mg
Comparator Risperidone Other / unclassified 4 mg

Indications